ARROWHEAD PHARMACEUTICALS, INC. Quarterly Unrecognized Tax Benefits in USD from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q3 2019 to Q3 2023.
  • Arrowhead Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending September 30, 2023 was $14.5M, a 318% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $14.5M +$11.1M +318% Sep 30, 2023 10-K 2023-11-29
Q3 2022 $3.48M +$3.48M Sep 30, 2022 10-K 2023-11-29
Q3 2021 $0 $0 Sep 30, 2021 10-K 2023-11-29
Q3 2020 $0 $0 Sep 30, 2020 10-K 2023-11-29
Q3 2019 $0 Sep 30, 2019 10-K 2022-11-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.